PortfoliosLab logoPortfoliosLab logo
FLGT vs. VTR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

FLGT vs. VTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fulgent Genetics, Inc. (FLGT) and Ventas, Inc. (VTR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FLGT achieves a -30.80% return, which is significantly lower than VTR's 11.03% return.


FLGT

1D
1.91%
1M
6.25%
YTD
-30.80%
6M
-33.06%
1Y
-5.95%
3Y*
-21.12%
5Y*
-26.29%
10Y*

VTR

1D
2.81%
1M
-3.19%
YTD
11.03%
6M
9.27%
1Y
38.07%
3Y*
28.37%
5Y*
11.77%
10Y*
6.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FLGT vs. VTR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FLGT
Fulgent Genetics, Inc.
-30.80%42.23%-36.11%-2.92%-70.39%93.07%303.88%306.94%-27.63%-62.14%
VTR
Ventas, Inc.
11.03%35.09%22.24%15.06%-8.53%7.73%-9.80%3.42%3.45%0.71%

Correlation

The correlation between FLGT and VTR is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Sep 29, 2016

0.10

The correlation between FLGT and VTR shifts across timeframes, from 0.03 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

FLGT:

$561.42M

VTR:

$41.55B

EPS

FLGT:

-$2.40

VTR:

$0.55

PS Ratio

FLGT:

1.75

VTR:

6.58

PB Ratio

FLGT:

0.53

VTR:

3.17

Total Revenue (TTM)

FLGT:

$320.35M

VTR:

$6.13B

Gross Profit (TTM)

FLGT:

$121.99M

VTR:

-$261.17M

EBITDA (TTM)

FLGT:

-$67.18M

VTR:

$2.45B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FLGT vs. VTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FLGT
FLGT Risk / Return Rank: 3939
Overall Rank
FLGT Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
FLGT Sortino Ratio Rank: 3838
Sortino Ratio Rank
FLGT Omega Ratio Rank: 4141
Omega Ratio Rank
FLGT Calmar Ratio Rank: 3939
Calmar Ratio Rank
FLGT Martin Ratio Rank: 3838
Martin Ratio Rank

VTR
VTR Risk / Return Rank: 8787
Overall Rank
VTR Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
VTR Sortino Ratio Rank: 8787
Sortino Ratio Rank
VTR Omega Ratio Rank: 8686
Omega Ratio Rank
VTR Calmar Ratio Rank: 8484
Calmar Ratio Rank
VTR Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FLGT vs. VTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fulgent Genetics, Inc. (FLGT) and Ventas, Inc. (VTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FLGTVTRDifference
Sharpe ratioReturn per unit of total volatility

-2.05

Sortino ratioReturn per unit of downside risk

-2.53

Omega ratioGain probability vs. loss probability

1.05

1.36

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.11

3.06

-3.16

Martin ratioReturn relative to average drawdown

-0.21

10.85

-11.06

FLGT vs. VTR - Sharpe Ratio Comparison

The current FLGT Sharpe Ratio is -0.10, which is lower than the VTR Sharpe Ratio of 1.95. The chart below compares the historical Sharpe Ratios of FLGT and VTR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FLGT vs. VTR - Drawdown Comparison

The maximum FLGT drawdown since its inception was -92.50%, which is greater than VTR's maximum drawdown of -83.84%. Use the drawdown chart below to compare losses from any high point for FLGT and VTR.


Loading charts...

Drawdown Indicators


FLGTVTRDifference

Max Drawdown

Largest peak-to-trough decline

-92.50%

-83.84%

-8.66%

Max Drawdown (1Y)

Largest decline over 1 year

-55.30%

-12.52%

-42.78%

Max Drawdown (3Y)

Largest decline over 3 years

-66.21%

-19.35%

-46.86%

Max Drawdown (5Y)

Largest decline over 5 years

-87.56%

-41.80%

-45.76%

Max Drawdown (10Y)

Largest decline over 10 years

-76.92%

Current Drawdown

Current decline from peak

-90.11%

-5.51%

-84.60%

Average Drawdown

Average peak-to-trough decline

-61.70%

-18.37%

-43.33%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.04%

3.52%

+24.52%

Volatility

FLGT vs. VTR - Volatility Comparison

Fulgent Genetics, Inc. (FLGT) has a higher volatility of 12.02% compared to Ventas, Inc. (VTR) at 9.37%. This indicates that FLGT's price experiences larger fluctuations and is considered to be riskier than VTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FLGTVTRDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.02%

9.37%

+2.65%

Volatility (6M)

Calculated over the trailing 6-month period

56.70%

15.32%

+41.38%

Volatility (1Y)

Calculated over the trailing 1-year period

57.50%

19.71%

+37.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.11%

25.05%

+26.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.57%

34.81%

+40.76%

Dividends

FLGT vs. VTR - Dividend Comparison

FLGT has not paid dividends to shareholders, while VTR's dividend yield for the trailing twelve months is around 2.30%.


PositionTTM20252024202320222021202020192018201720162015
FLGT
Fulgent Genetics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VTR
Ventas, Inc.
2.30%2.48%3.06%3.61%4.00%3.52%4.37%5.49%5.40%5.19%4.74%20.47%

Financials

FLGT vs. VTR - Financials Comparison

This section allows you to compare key financial metrics between Fulgent Genetics, Inc. and Ventas, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
71.14M
1.66B
(FLGT) Total Revenue
(VTR) Total Revenue
Values in USD except per share items

FLGT vs. VTR - Profitability Comparison

The chart below illustrates the profitability comparison between Fulgent Genetics, Inc. and Ventas, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
27.4%
39.6%
Portfolio components
FLGT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported a gross profit of 19.46M and revenue of 71.14M. Therefore, the gross margin over that period was 27.4%.

VTR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ventas, Inc. reported a gross profit of 655.41M and revenue of 1.66B. Therefore, the gross margin over that period was 39.6%.

FLGT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported an operating income of -34.62M and revenue of 71.14M, resulting in an operating margin of -48.7%.

VTR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ventas, Inc. reported an operating income of 191.56M and revenue of 1.66B, resulting in an operating margin of 11.6%.

FLGT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Fulgent Genetics, Inc. reported a net income of -24.83M and revenue of 71.14M, resulting in a net margin of -34.9%.

VTR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ventas, Inc. reported a net income of 55.91M and revenue of 1.66B, resulting in a net margin of 3.4%.


Frequently Asked Questions


FLGT and VTR have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FLGT has higher volatility (12.02%) compared to VTR (9.37%). In terms of maximum drawdown, FLGT dropped -92.50% vs VTR's -83.84%.

VTR currently has the higher Sharpe Ratio (1.95 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FLGT and VTR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer